Germline loss-of-function <i>BRCA1</i> and <i>BRCA2</i> mutations and risk of <i>de novo</i> hematopoietic malignancies

• Ryan J. Stubbins,
• Anase S. Asom,
• Peng Wang,
• Angela M. Lager,
• Alexander Gary,
• Lucy A. Godley

Affiliations

Ryan J. Stubbins

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, BC, V5N 5K9, Canada; Leukemia/BMT Program of BC, BC Cancer, Vancouver, BC, V5N 5K9

Anase S. Asom

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, 60637

Peng Wang

Department of Pathology, The University of Chicago, Chicago, IL, 60637

Angela M. Lager

Department of Pathology, The University of Chicago, Chicago, IL, 60637

Alexander Gary

Department of Pathology, The University of Chicago, Chicago, IL, 60637

Lucy A. Godley

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA; Department of Human Genetics, The University of Chicago, Chicago, IL, 60637